Meclizine Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 25 mg
Reference Brands: Antivert, Bonine, Dramamine(US)
Category:
Antiemetic
Meclizine is an antihistamine that blocks H1 receptors, reducing vestibular activity and nausea. It effectively prevents and relieves motion sickness, vertigo, and dizziness. Benefits include rapid symptom relief, improved balance, decreased nausea, and support for inner ear disorders, enhancing comfort and safety during travel or vestibular dysfunction.
Meclizine tablet is available in Tablets
and strengths such as 25 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Meclizine tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Meclizine tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Meclizine tablets, marketed as Antivert and branded generics, are approved in the US by the FDA and in the EU via EMA for motion sickness, vertigo, and nausea. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional requirements supports swift approval, safe usage, and global availability, helping patients worldwide manage vestibular issues and nausea effectively for improved safety and comfort.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing